- Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. Tortora, G., Caputo, R., Damiano, V., Fontanini, G., Melisi, D., Veneziani, B.M., Zunino, F., Bianco, A.R., Ciardiello, F. Clin. Cancer Res. (2001)